Related Experiment Video

Updated: Oct 15, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Workshop to identify critical windows of exposure for children's health: cardiovascular and endocrine work group

M Barr1, J M DeSesso, C S Lau

  • 1Departments of Pediatrics, Pathology and Obstetrics, University of Michigan, Ann Arbor, Michigan, USA. barr@umich.edu

Environmental Health Perspectives
|June 15, 2000
PubMed

Insights

Children have specific vulnerable periods for developmental toxicants, impacting cardiovascular and endocrine systems. Understanding these windows is crucial for improving risk assessment and public health strategies.

Area of Science:

  • Environmental Health
  • Developmental Toxicology
  • Pediatric Health

Background:

  • Children possess unique windows of vulnerability to environmental toxicants.
  • Cardiovascular and endocrine systems are susceptible to developmental toxicants during critical periods.
  • Assessing risks to children's health requires understanding these vulnerabilities.

Purpose of the Study:

  • To review current knowledge on children's windows of vulnerability to developmental toxicants.
  • To recommend improvements in risk assessment and public health strategies.
  • To differentiate vulnerability periods for structural versus functional defects.

Main Methods:

  • Literature review on developmental toxicants and children's vulnerability.
  • Analysis of established knowledge on cardiovascular and endocrine system development.
  • Comparison of vulnerability windows for structural and functional defects.

Main Results:

  • Periods of vulnerability are well-defined for structural defects.
  • Periods of vulnerability are often elusive for functional defects.
  • Current knowledge highlights the complexity of assessing risks for functional deficits.

Conclusions:

  • Improved risk assessment requires a nuanced understanding of vulnerability windows.
  • Public health strategies must account for the distinct nature of structural and functional defects.
  • Further research is needed to define elusive vulnerability periods for functional defects.

More Related Videos

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Using Chicken Embryo as a Powerful Tool in Assessment of Developmental Cardiotoxicities11:00

Using Chicken Embryo as a Powerful Tool in Assessment of Developmental Cardiotoxicities

Published on: March 21, 2021

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...